New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - midazolam 1 mg/ml;   - solution for injection - 1 mg/ml - active: midazolam 1 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - conscious sedation before diagnostic or surgical interventions carried out under local anaesthesia (intravenous administration), or in children intranasal or oral administration. long-term sedation in intensive care units (intravenous administration as bolus injection or continuous infusion).

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - midazolam 5 mg/ml;   - solution for injection - 5 mg/ml - active: midazolam 5 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - conscious sedation before diagnostic or surgical interventions carried out under local anaesthesia (intravenous administration), or in children intranasal or oral administration. long-term sedation in intensive care units (intravenous administration as bolus injection or continuous infusion).

New Zealand - English - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - beclometasone dipropionate 100ug (0.169%) - aerosol inhaler, metered dose - 100 mcg/dose - active: beclometasone dipropionate 100ug (0.169%) excipient: ethanol norflurane - prophylactic anti-inflammatory treatment of reversible obstructive airways disease including asthma.

New Zealand - English - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - beclometasone dipropionate 50ug (0.084%) - aerosol inhaler, metered dose - 50 mcg/dose - active: beclometasone dipropionate 50ug (0.084%) excipient: ethanol norflurane - prophylactic anti-inflammatory treatment of reversible obstructive airways disease including asthma.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - salbutamol sulfate 120ug equivalent to salbutamol 100 µg;   - aerosol inhaler, metered dose - 100 mcg/dose - active: salbutamol sulfate 120ug equivalent to salbutamol 100 µg   excipient: ethanol norflurane oleic acid - with its fast onset of action, it is particularly suitable for the management and prevention of attack in mild asthma and for the treatment of acute exacerbations in moderate and severe asthma.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - sotalol hydrochloride 10 mg/ml - solution for injection - 40mg/4ml - active: sotalol hydrochloride 10 mg/ml

European Union - English - EMA (European Medicines Agency)

novartis europharm limited - crizanlizumab - anemia, sickle cell - other hematological agents - adakveo is indicated for the prevention of recurrent vaso occlusive crises (vocs) in sickle cell disease patients aged 16 years and older.it can be given as an add on therapy to hydroxyurea/hydroxycarbamide (hu/hc) or as monotherapy in patients for whom hu/hc is inappropriate or inadequate.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - ibuprofen, quantity: 200 mg; codeine phosphate hemihydrate, quantity: 12.8 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; colloidal anhydrous silica; pregelatinised maize starch; titanium dioxide; hypromellose; macrogol 400 - for temporary relief of acute moderate pain and inflammation in patients over the age of 12 years (see also section contraindications and special warnings and precuations for use - paediatric use)

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - mirtazapine -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - mirtazapine -